1. Exploration of Immune Tolerance and Treatment for Esophageal Cancer
- Author
-
XING Siyuan, FAN Qingxia, SHAN Zhengzheng, MENG Xiangrui, and WANG Feng
- Subjects
cancer immune evasion ,tumor immune microenvironment ,regulatory t cell ,cancer-associated fibroblast ,cancer immunotherapy ,targeted therapy ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Monoclonal antibody drugs that inhibit programmed death 1 (PD-1) or programmed death ligand 1 (PD-L1) have been widely used in esophageal cancer (EC) and yielded significant therapeutic responses. However, only a few patients obtain lasting clinical benefits due to primary or acquired drug resistance, and new treatment schemes are urgently needed. The tumor immune microenvironment is the main factor that affects patients' response to immunosuppressive agents. This article will discuss the role of immunosuppressive cells and non-cellular components in the immune process to provide ideas for the next research direction of EC.
- Published
- 2023
- Full Text
- View/download PDF